Thirona secures patent to implement AI for the early detection of cystic fibrosis patients
The AI medical image analysis company, which focuses on respiratory conditions, earned a license permitting it to develop an AI tool to analyze lung scans and more efficiently detect the progression of cystic fibrosis (CF) in children, according to MobiHealthNews. Thirona’s LungQ software will help clinicians detect and determine the extent of CF lung disease. CF is a rare condition without a cure that affects 70,000 patients globally—most of whom are diagnosed in early childhood.
As seen in: